| Name | Value |
|---|---|
| Revenues | 152.0K |
| Cost of Revenue | 154.0K |
| Gross Profit | -2.0K |
| Operating Expense | 3,145.0K |
| Operating I/L | -3,147.0K |
| Other Income/Expense | -781.0K |
| Interest Income | 0.0K |
| Pretax | -3,928.0K |
| Income Tax Expense | 0.0K |
| Net Income/Loss | -3,928.0K |
Helius Medical Technologies, Inc. is a neurotechnology company specializing in non-invasive technologies for treating symptoms of neurological disease or trauma. Its flagship product, the Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device designed for short-term treatment of gait deficit in multiple sclerosis and balance deficit in mild-to-moderate traumatic brain injury. The device is used in conjunction with supervised therapeutic exercise, offering a unique solution for patients. Helius generates revenue through the development, licensing, and acquisition of innovative medical technologies, positioning itself as a leader in the neurotechnology industry.